Gotham Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50.2M | Buy |
102,065
+29,307
| +40% | +$15.9M | 0.15% | 104 |
|
|
2025
Q4 | $42.2M | Buy |
72,758
+982
| +1% | +$555K | 0.15% | 101 |
|
|
2025
Q3 | $34.8M | Sell |
71,776
-7,986
| -10% | -$3.72M | 0.15% | 116 |
|
|
2025
Q2 | $32.3M | Buy |
79,762
+41,418
| +108% | +$17.3M | 0.19% | 55 |
|
|
2025
Q1 | $19.1M | Buy |
38,344
+8,993
| +31% | +$4.87M | 0.16% | 128 |
|
|
2024
Q4 | $15.3M | Buy |
29,351
+5,944
| +25% | +$3.27M | 0.14% | 161 |
|
|
2024
Q3 | $14.5M | Buy |
23,407
+2,125
| +10% | +$1.26M | 0.15% | 148 |
|
|
2024
Q2 | $11.8M | Buy |
21,282
+7,164
| +51% | +$4.1M | 0.15% | 128 |
|
|
2024
Q1 | $8.21M | Buy |
14,118
+9,218
| +188% | +$5.17M | 0.12% | 199 |
|
|
2023
Q4 | $2.6M | Buy |
4,900
+2,246
| +85% | +$1.09M | 0.05% | 515 |
|
|
2023
Q3 | $1.34M | Buy |
2,654
+855
| +48% | +$456K | 0.03% | 678 |
|
|
2023
Q2 | $939K | Sell |
1,799
-702
| -28% | -$379K | 0.02% | 793 |
|
|
2023
Q1 | $1.44M | Sell |
2,501
-1,798
| -42% | -$1.01M | 0.03% | 620 |
|
|
2022
Q4 | $2.37M | Buy |
4,299
+2,330
| +118% | +$1.23M | 0.07% | 368 |
|
|
2022
Q3 | $999K | Buy |
1,969
+75
| +4% | +$42K | 0.03% | 653 |
|
|
2022
Q2 | $1.03M | Sell |
1,894
-5,089
| -73% | -$2.8M | 0.03% | 558 |
|
|
2022
Q1 | $4.13M | Sell |
6,983
-2,561
| -27% | -$1.47M | 0.13% | 193 |
|
|
2021
Q4 | $6.37M | Buy |
9,544
+6,863
| +256% | +$4.28M | 0.21% | 111 |
|
|
2021
Q3 | $1.53M | Sell |
2,681
-9,953
| -79% | -$5.46M | 0.06% | 372 |
|
|
2021
Q2 | $6.37M | Sell |
12,634
-15,202
| -55% | -$7.17M | 0.27% | 98 |
|
|
2021
Q1 | $12.7M | Sell |
27,836
-2,136
| -7% | -$1.02M | 0.57% | 18 |
|
|
2020
Q4 | $14M | Buy |
29,972
+17,365
| +138% | +$8.14M | 0.46% | 33 |
|
|
2020
Q3 | $5.57M | Buy |
12,607
+11,093
| +733% | +$4.58M | 0.18% | 169 |
|
|
2020
Q2 | $549K | Sell |
1,514
-1,009
| -40% | -$338K | 0.02% | 722 |
|
|
2020
Q1 | $716K | Buy |
2,523
+1,075
| +74% | +$339K | 0.02% | 643 |
|
|
2019
Q4 | $470K | Sell |
1,448
-1,715
| -54% | -$520K | 0.01% | 832 |
|
|
2019
Q3 | $921K | Sell |
3,163
-13,498
| -81% | -$3.87M | 0.02% | 604 |
|
|
2019
Q2 | $4.89M | Sell |
16,661
-23,940
| -59% | -$6.59M | 0.08% | 322 |
|
|
2019
Q1 | $11.1M | Buy |
40,601
+1,181
| +3% | +$294K | 0.16% | 180 |
|
|
2018
Q4 | $8.82M | Buy |
39,420
+25,830
| +190% | +$6.06M | 0.14% | 220 |
|
|
2018
Q3 | $3.32M | Buy |
+13,590
| New | +$3.13M | 0.05% | 419 |
|
|
2017
Q3 | – | Sell |
-2,478
| Closed | -$432K | – | 1042 |
|
|
2017
Q2 | $432K | Sell |
2,478
-8,413
| -77% | -$1.41M | 0.01% | 774 |
|
|
2017
Q1 | $1.67M | Buy |
+10,891
| New | +$1.66M | 0.02% | 577 |
|
|
2016
Q3 | – | Sell |
-1,790
| Closed | -$264K | – | 1046 |
|
|
2016
Q2 | $264K | Sell |
1,790
-2,897
| -62% | -$428K | ﹤0.01% | 836 |
|
|
2016
Q1 | $664K | Buy |
+4,687
| New | +$628K | 0.01% | 715 |
|
|
2014
Q4 | – | Sell |
-3,314
| Closed | -$403K | – | 1043 |
|
|
2014
Q3 | $403K | Buy |
+3,314
| New | +$403K | ﹤0.01% | 800 |
|
Other funds holding TMO
VCM
Gotham Asset Management's TMO Position: Q1 2026 in Review
Gotham Asset Management increased its Thermo Fisher Scientific (TMO) stake by 40% in Q1 2026, buying an estimated $15.9M and bringing the position to 102,065 shares worth $50.2M. The position accounts for 0.15% of the portfolio, ranked #104.
Gotham Asset Management first reported a position in TMO in Q3 2014 and has held it in 36 quarters since. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Gotham Asset Management held 102,065 shares of Thermo Fisher Scientific worth $50.2M as of Q1 2026.
- Gotham Asset Management bought 29,307 Thermo Fisher Scientific shares in Q1 2026, an estimated $15.9M.
- Thermo Fisher Scientific made up 0.15% of Gotham Asset Management's portfolio in Q1 2026, its #104 holding.
- Gotham Asset Management first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 36 quarters since.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.